Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Obesity Surgery
Erschienen in: Obesity Surgery 1/2018

14.11.2017 | White Paper

ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management

verfasst von: Marvin Ryou, Kenneth R. McQuaid, Christopher C. Thompson, Steven Edmundowicz, Klaus Mergener, ASGE EndoVators Task Force

Erschienen in: Obesity Surgery | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

On November 20 and 21, 2016, the American Society for Gastrointestinal Endoscopy (ASGE) and the Association for Bariatric Endoscopy (ABE) hosted the EndoVators Summit at the Institute for Training and Technology in Downers Grove, Illinois to define the role and value of endoscopic therapies in obesity management. Nearly 100 obesity management experts, innovators, and key decision makers from industry, insurers, and regulatory agencies gathered to review the current state of the obesity epidemic in America and the role that endoscopic bariatric and metabolic therapies (EBMTs) could play in the management of this chronic disease. Additionally, ASGE invited leaders of societies with an interest in EBMTs to participate in an exchange of ideas related to the training, research, and education in EBMTs with the goal of identifying areas of cooperation and coordination. The following societies were represented:
  • American Society for Gastrointestinal Endoscopy
  • The Association for Bariatric Endoscopy
  • American Society for Metabolic and Bariatric Surgery
  • International Federation for the Surgery of Obesity and Metabolic Disorders
  • The Obesity Society
  • American Association for the Study of Liver Diseases
  • American Society of Transplantation
  • American College of Gastroenterology
  • Academy of Nutrition and Dietetics
  • North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition
  • Society of American Gastrointestinal and Endoscopic Surgeons
…
Literatur
1.
Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–1.CrossRefPubMed
2.
3.
Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015;219:1–8.
4.
Ogden CL, Lamb M, Carroll M, et al. Obesity and socioeconomic status in adults: United States, 2005-2008. NCHS Data Brief. 2010;50:1–8.
5.
6.
Finkelstein E, Trogdon J, Cohen J, et al. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff. 2009;28:w822–31.CrossRef
7.
Arterburn DE, Maciejewski M, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obes. 2005;29:334–9.CrossRef
8.
Centers for Disease Control and Prevention (CDC). Adverse childhood experiences reported by adults—five states, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1609–13.
9.
Fellitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study. Am J Prev Med. 1998;14:245–58.CrossRef
10.
Lodhia NA, Rosas U, Moore M, et al. Do adverse childhood experiences affect surgical weight loss outcomes? J Gastrointest Surg. 2015;19:993–8.CrossRefPubMed
11.
Bray GA. Obesity illustrated. In: An atlas of obesity and weight control. New York: Parthenon Publishing; 2003. p. 79.
12.
13.
Nielsen SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1998. JAMA. 2003;189:450–3.CrossRef
14.
Powell E. Recent trends in added sugar intake among U.S. children and adults from 1977 to 2010. Poster abstract presented at: The Obesity Society Annual Meeting at Obesity Week 2014; November 2–7, 2014; Boston.
15.
Hu FB, Lee TY, Colditz GA, et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289:1785–91.CrossRefPubMed
16.
Ladabaum U, Mannalithara A, Myer PA, et al. Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. Am J Med. 2014;127:717–27.CrossRefPubMedPubMedCentral
17.
Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science. 2005;307:1909–14.CrossRefPubMed
18.
Korner J, Leibel RL. To eat or not to eat—how the gut talks to the brain. N Engl J Med. 2003;349:926–8.CrossRefPubMed
19.
Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1696–705.CrossRefPubMed
20.
Siegel KR, McKeever B, Imperatore G, et al. Association of higher consumption of foods derived from subsidized commodities with adverse cardiometabolic risk among US adults. JAMA Intern Med. 2016;176:1124–32.CrossRefPubMed
21.
Seligman HK, Schillinger D. Hunger and socioeconomic disparities in chronic disease. N Engl J Med. 2010;363:6–9.CrossRefPubMed
22.
Seligman HK, Laraia BA, Kushel MB. Food insecurity is associated with chronic disease among low-income NHANES participants. J Nutr. 2010;140:304–10.CrossRefPubMedPubMedCentral
23.
Malik VS, Hu FB. Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us. J Am Coll Cardiol. 2015;66:1615–24.CrossRefPubMedPubMedCentral
24.
Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002;288:475–82.CrossRefPubMed
25.
Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis. 2014;56:465–72.CrossRefPubMed
26.
Price JH, Desmond SM, Krol RA, et al. Family practice physicians’ beliefs, attitudes, and practices regarding obesity. Am J Prev Med. 1987;3:339–45.PubMed
27.
Hill JO, Wyatt H. Outpatient management of obesity: a primary care perspective. Obes Res. 2002;10(suppl):124S–30S.CrossRefPubMed
28.
Moyer VA, U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157:378.
29.
Lefevre MLS, U.S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;161:587–93.CrossRefPubMed
30.
Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity: executive summary. Endocr Pract. 2016;22:842–84.CrossRefPubMed
31.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.CrossRefPubMed
32.
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63:2985–3023.CrossRefPubMed
33.
Apovian CM, Arrone LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342–62.CrossRefPubMed
34.
35.
36.
Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125:1157–70.CrossRefPubMedPubMedCentral
37.
Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRef
38.
Dombrowski SU, Knittle K, Avenell A, et al. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomized controlled trials. BMJ. 2014;348:g2646.CrossRefPubMedPubMedCentral
39.
Hamdy O, Carver C. The why WAIT program: improving clinical outcomes through weight management in type 2 diabetes. Curr Diab Rep. 2008;8:413–20.CrossRefPubMed
40.
Hamdy O, Mottalib A, Morsi A, et al. Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study. BMJ Open Diabetes Res Care. 2017;5(1):e000259.CrossRefPubMedPubMedCentral
41.
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRefPubMed
42.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.CrossRefPubMed
43.
Diamantis T, Apostolou KG, Alexandrou A, et al. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10:177–83.CrossRefPubMed
44.
Young MT, Gebhart A, Phelan MJ, et al. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg. 2015;220:880–5.CrossRefPubMed
45.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3 year outcomes. N Engl J Med. 2014;370:2002–13.CrossRefPubMedPubMedCentral
46.
National Institute for Health and Care Excellence. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults: partial update of CG43. National Clinical Guideline Centre, 2014.
47.
Cohen R, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35:1420–8.CrossRefPubMedPubMedCentral
48.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23.PubMed
49.
ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh BK, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–38.CrossRef
50.
Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–53.CrossRefPubMed
51.
A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis 2011;7:672–682.
52.
Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11:874–81.CrossRefPubMed
53.
Sullivan S, Swain JM, Woodman G, et al. The Obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6-month randomized sham controlled trial. Gastroenterology. 2016;150(4 suppl 1):S126.
54.
Thompson CC, Abu Dayyeh BK, Kushner R, et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol. 2017;112:447–57.CrossRefPubMed
55.
Lopez-Nava G, Sharaiha RZ, Galvao Neto M, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up. Gastroenterology. 2016;150(4 suppl 1):S26.CrossRef
56.
Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity. 2017;25:294–301.CrossRefPubMed
57.
Mingrone G, Panuzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577–1585.
58.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51.CrossRefPubMedPubMedCentral
59.
Nauck M, Stockmann F, Ebert R, et al. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29:46–52.CrossRefPubMed
60.
Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009;11:725–32.CrossRefPubMed
61.
Koehestanie P, de Jonge C, Berends FJ, et al. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 2014;260:984–992.
62.
Rajagopalan H, Cherington AD, Thompson CC, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016;39:2254–61.CrossRefPubMed
63.
Machytka E, Buzga M, Ryou M, et al. Endoscopic dual-path enteral bypass using a magnetic incisionless anastomosis system (IAS). Gastrointest Endosc. 2016;83:AB196.CrossRef
64.
Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20:377–88.CrossRefPubMedPubMedCentral
65.
MacLean PS, Wing RR, Davidson T, et al. NIH working group report: innovative research to improve maintenance of weight loss. Obesity. 2015;23:7–15.CrossRefPubMed
Metadaten
Titel
ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
verfasst von
Marvin Ryou
Kenneth R. McQuaid
Christopher C. Thompson
Steven Edmundowicz
Klaus Mergener
ASGE EndoVators Task Force
Publikationsdatum
14.11.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 1/2018
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2948-3

Weitere Artikel der Ausgabe 1/2018

Obesity Surgery 1/2018 Zur Ausgabe

Original Contributions

The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery

Letter to the Editor

Letter to the Editor: Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014

Original Contributions

Roux-en-Y Gastric Bypass Aggravates Vitamin A Deficiency in the Mother-Child Group

Brief Communication

Increased Free Testosterone Levels in Men with Uncontrolled Type 2 Diabetes Five Years After Randomization to Bariatric Surgery

Original Contributions

Perioperative Practices Concerning One Anastomosis (Mini) Gastric Bypass: A Survey of 210 Surgeons

Original Contributions

Single Anastomosis Duodeno-Ileal Switch (SADIS): A Systematic Review of Efficacy and Safety

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.